Cargando…
The South African Regulatory System: Past, Present, and Future
The drive for improved regulatory systems and the establishment of a more effective regulatory framework in South Africa has been evident for the past two decades but despite political intentions and legislative revisions success has been limited to date. Efforts to address the increasing volume of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300068/ https://www.ncbi.nlm.nih.gov/pubmed/30618735 http://dx.doi.org/10.3389/fphar.2018.01407 |
_version_ | 1783381617293656064 |
---|---|
author | Keyter, Andrea Banoo, Shabir Salek, Sam Walker, Stuart |
author_facet | Keyter, Andrea Banoo, Shabir Salek, Sam Walker, Stuart |
author_sort | Keyter, Andrea |
collection | PubMed |
description | The drive for improved regulatory systems and the establishment of a more effective regulatory framework in South Africa has been evident for the past two decades but despite political intentions and legislative revisions success has been limited to date. Efforts to address the increasing volume of applications that have been received have to date failed and resources have been stretched to capacity resulting in the development of a significant backlog and extended timelines for product registration. The promulgation of the recently amended Medicines and Related Substance Act of 1965 triggered the establishment of the South African Health Products Regulatory Authority (SAHPRA) as a separate juristic person outside of the National Department of Health to replace the former medicine regulatory authority the Medicines Control Council (MCC). The aim of this review is to provide the historical context supporting the new regulatory environment in South Africa and the transition from the MCC to SAHPRA. Key recommendations to SAHPRA to ensure the full potential of the new regulatory environment in South Africa include: establishing a quality management system to safeguard accountability, consistency and transparency and to streamline the implementation of good review practices including quality decision-making practices and benefit-risk assessment; the measurement and monitoring of regulatory performance, targets for overall approval time and key review milestones to instill a culture of accurate metrics collection and measurement of key performance indicators and their continuous improvement and the employment of a risk-based approach to the evaluation of medical products and codify the use of facilitated regulatory pathways in policy and culture. The application of a risk-based approach to regulatory review commensurate with a product’s risk to patients will facilitate the application of increased resources for pharmacovigilance activities and to support the reliance and recognition of reference agencies. |
format | Online Article Text |
id | pubmed-6300068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63000682019-01-07 The South African Regulatory System: Past, Present, and Future Keyter, Andrea Banoo, Shabir Salek, Sam Walker, Stuart Front Pharmacol Pharmacology The drive for improved regulatory systems and the establishment of a more effective regulatory framework in South Africa has been evident for the past two decades but despite political intentions and legislative revisions success has been limited to date. Efforts to address the increasing volume of applications that have been received have to date failed and resources have been stretched to capacity resulting in the development of a significant backlog and extended timelines for product registration. The promulgation of the recently amended Medicines and Related Substance Act of 1965 triggered the establishment of the South African Health Products Regulatory Authority (SAHPRA) as a separate juristic person outside of the National Department of Health to replace the former medicine regulatory authority the Medicines Control Council (MCC). The aim of this review is to provide the historical context supporting the new regulatory environment in South Africa and the transition from the MCC to SAHPRA. Key recommendations to SAHPRA to ensure the full potential of the new regulatory environment in South Africa include: establishing a quality management system to safeguard accountability, consistency and transparency and to streamline the implementation of good review practices including quality decision-making practices and benefit-risk assessment; the measurement and monitoring of regulatory performance, targets for overall approval time and key review milestones to instill a culture of accurate metrics collection and measurement of key performance indicators and their continuous improvement and the employment of a risk-based approach to the evaluation of medical products and codify the use of facilitated regulatory pathways in policy and culture. The application of a risk-based approach to regulatory review commensurate with a product’s risk to patients will facilitate the application of increased resources for pharmacovigilance activities and to support the reliance and recognition of reference agencies. Frontiers Media S.A. 2018-12-04 /pmc/articles/PMC6300068/ /pubmed/30618735 http://dx.doi.org/10.3389/fphar.2018.01407 Text en Copyright © 2018 Keyter, Banoo, Salek and Walker. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Keyter, Andrea Banoo, Shabir Salek, Sam Walker, Stuart The South African Regulatory System: Past, Present, and Future |
title | The South African Regulatory System: Past, Present, and Future |
title_full | The South African Regulatory System: Past, Present, and Future |
title_fullStr | The South African Regulatory System: Past, Present, and Future |
title_full_unstemmed | The South African Regulatory System: Past, Present, and Future |
title_short | The South African Regulatory System: Past, Present, and Future |
title_sort | south african regulatory system: past, present, and future |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300068/ https://www.ncbi.nlm.nih.gov/pubmed/30618735 http://dx.doi.org/10.3389/fphar.2018.01407 |
work_keys_str_mv | AT keyterandrea thesouthafricanregulatorysystempastpresentandfuture AT banooshabir thesouthafricanregulatorysystempastpresentandfuture AT saleksam thesouthafricanregulatorysystempastpresentandfuture AT walkerstuart thesouthafricanregulatorysystempastpresentandfuture AT keyterandrea southafricanregulatorysystempastpresentandfuture AT banooshabir southafricanregulatorysystempastpresentandfuture AT saleksam southafricanregulatorysystempastpresentandfuture AT walkerstuart southafricanregulatorysystempastpresentandfuture |